Parkman Healthcare Partners’s Xencor XNCR Stock Holding History

Parkman Healthcare Partners’s Portfolio XNCR Stock Details XNCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,000	Closed	-$860K	–	77
2019 Q4	$860K	Buy	+25,000	New	+$913K	0.25%	64

Other funds holding XNCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Parkman Healthcare Partners's XNCR Position: Q1 2020 in Review

Parkman Healthcare Partners sold out of Xencor (XNCR) in Q1 2020, closing a stake of 25,000 shares — an estimated $860K sold.

Parkman Healthcare Partners first reported a position in XNCR in Q4 2019 and held it in 1 quarter. The position peaked at $860K in Q4 2019. 144 funds tracked by Wall St. Rank hold XNCR as of Q1 2020.

Parkman Healthcare Partners reported no remaining Xencor position as of Q1 2020 after selling out during the quarter.
Parkman Healthcare Partners sold 25,000 Xencor shares in Q1 2020, an estimated $860K.
Parkman Healthcare Partners first reported a position in Xencor in Q4 2019 and held it in 1 quarter.
Parkman Healthcare Partners's Xencor position peaked at $860K in Q4 2019.
144 funds tracked by Wall St. Rank held Xencor as of Q1 2020.

Based on Parkman Healthcare Partners's 13F filing for Q1 2020, filed 15 May 2020.